Allergan to Acquire Oculeve

Dublin, Ireland-based Allergan announced it will acquire San Francisco-based Oculeve for a $125 million upfront payment plus milestone payments related to Oculeve’s lead development program OD-01, a device to treat dry eye disease. The agreement also includes the acquisition of an additional earlier-stage dry eye device development program.

Full Story

This entry was posted in Uncategorized. Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

w

Connecting to %s